Quart Barry D - Insider Non-Derivative Transactions at Kiniksa Pharmaceuticals, Ltd. (KNSA) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 15, 2025, Quart Barry D's relationship to Kiniksa Pharmaceuticals, Ltd. (KNSA) is Director, and currently has 9,373 shares of Class A Common Share, and 32,675 shares of Class A Ordinary Share.

The charts below show the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other KNSA insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Quart Barry D - Insider Non-Derivative Transactions of KNSA Class A Common Share

Quart Barry D - Insider Non-Derivative Transactions of KNSA Class A Ordinary Share

Quart Barry D - Insider Non-Derivative Transactions at KNSA

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 16, 2025	Sell -- (Class A Ordinary Share)	20129	41.51	12546
Dec 16, 2025	M -- (Class A Ordinary Share)	20129	10.36	32675
Jun 12, 2025	Sell -- (Class A Ordinary Share)	12336	30.39	12546
Jun 12, 2025	M -- (Class A Ordinary Share)	12336	3.8	24882
Jun 11, 2025	Sell -- (Class A Ordinary Share)	8212	30.36	12546
Jun 11, 2025	M -- (Class A Ordinary Share)	8212	3.8	20758
Jun 10, 2025	Sell -- (Class A Ordinary Share)	6900	30.26	12546
Jun 10, 2025	M -- (Class A Ordinary Share)	6900	3.8	19446
Jun 6, 2025	M -- (Class A Ordinary Share)	3173	0	12546
Jun 7, 2024	M -- (Class A Common Share)	4373	0	9373
Jun 30, 2023	M -- (Class A Common Share)	5000	0	5000